ORIGEN THERAPEUTICS has a total of 19 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets biotechnology and agriculture are TRANXENOGEN INC, ORIGEN THERAPEUTICS INC and GENOWAY.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | United States | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Japan | 2 | |
#7 | China | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Agriculture |
# | Technology | |
---|---|---|
#1 | Animal care | |
#2 | Microorganisms | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Zhu Lei | 13 |
#2 | Etches Robert J | 12 |
#3 | Kay Robert M | 9 |
#4 | Van De Lavoir Marie-Cecile | 5 |
#5 | Etches Robert | 4 |
#6 | Winters-Digiacinto Peggy | 4 |
#7 | Beemer Kathleen | 3 |
#8 | Leighton Philip | 3 |
#9 | Mather Christine | 3 |
#10 | Myers Heather | 3 |
Publication | Filing date | Title |
---|---|---|
WO2009023800A1 | Transgenic chickens with an inactivated endogenous gene locus | |
US2010138946A1 | Transgenic chickens with an inactivated endogenous gene locus | |
AU2003230741A1 | Transgenic aves producing human polyclonal antibodies | |
US2003182675A1 | Functional disruption of avian immunoglobulin genes |